| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | Inquire | 10 μg | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT00001WQ is a type of small interfering RNA (siRNA) that targets A1BG gene and regulates the expression of gene. The siRNA interferes with the expression of A1BG gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT00001WQ is a type of small interfering RNA (siRNA) that targets A1BG gene and regulates the expression of gene. The siRNA interferes with the expression of A1BG gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Enterococcus are lactic acid bacteria; LAB comprising both pathogenic and commensal microorganisms ubiquitous in environment even as gut symbionts. They are extensively studied as potential candidate probiotics. Several number of Enterococcus strains have been reported to produce antimicrobial Enterococcus are lactic acid bacteria; LAB comprising both pathogenic and commensal microorganisms ubiquitous in environment even as gut symbionts. They are extensively studied as potential candidate probiotics. Several number of Enterococcus strains have been reported to produce antimicrobial compounds including bacteriocins. Bacteriocin production have be applied to preservation of a wide range of food products and is now being considered as a probiotic trait. Besides, bacteriocins are considered as promising alternative to fight emerging antimicrobial resistance. Enterococcus probiotics can be used in treatment and/or prevention of certain human and animal diseases such as alleviation of irritable bowel syndrome symptoms and antibiotic-induced diarrhea and prevention of different functional and chronic intestinal diseases. Moreover, some Enterococcus exhibit anticarcinogenic, hypocholesterolemic, as well as immune regulation effects.... Read More | This product GTVCR-WQ39MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA with 30 nt poly(A) tail ecoding antibody This product GTVCR-WQ39MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA with 30 nt poly(A) tail ecoding antibody which targeting VEGFA. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.... Read More | This membrane protein is Rat IL-2 R beta&IL-2 R gamma. We provide this protein to facilitate your membrane protein antibody discovery and development. | The product SIRGT34137WQ-LNA is a type of small interfering RNA (siRNA) that targets NFE2L3 gene and regulates the expression of gene. The siRNA interferes with the expression of NFE2L3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT34137WQ-LNA is a type of small interfering RNA (siRNA) that targets NFE2L3 gene and regulates the expression of gene. The siRNA interferes with the expression of NFE2L3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |